ArticleCureus2026
Bilateral Lower Extremity Necrotizing Fasciitis Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in a Liver Transplant Recipient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing fasciitis (NF) is a rapidly progressive and life-threatening soft tissue infection that typically affects a single extremity, whereas bilateral or multifocal involvement is rare and associated with high mortality. Gram-negative organisms, including extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, are uncommon causes but are increasingly recognized in immunocompromised patients and are often associated with fulminant clinical courses. We report a rare case of bilateral lower extremity NF caused by ESBL-producing E. coli in a woman in her seventies with a history of liver transplantation under long-term immunosuppression. The patient initially presented with bilateral lower leg erythema and swelling without necrosis, leading to a preliminary diagnosis of cellulitis. Despite antimicrobial therapy, her condition deteriorated with the development of systemic inflammatory response, coagulopathy, and subsequent localized necrosis. Imaging revealed subcutaneous gas, and surgical exploration confirmed NF. Both blood and wound cultures grew ESBL-producing E. coli, prompting escalation to carbapenem therapy. Repeated surgical debridement was performed, resulting in eventual infection control and successful limb preservation. This case highlights several important clinical considerations. First, NF caused by ESBL-producing E. coli may present with subtle early cutaneous findings despite rapid systemic deterioration, particularly in immunocompromised hosts. Second, bilateral involvement, although rare, should be considered in patients with risk factors such as chronic lymphedema and bacteremia. Finally, early recognition, prompt surgical exploration, and aggressive debridement combined with appropriate antimicrobial therapy are critical for survival and limb preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.